Zusammenfassung
Unter der Vielzahl möglicher Tumorerkrankungen sind primäre Neoplasien des Skeletts vergleichsweise selten. Primär maligne Knochentumoren zeigen eine jährliche Inzidenz von knapp 10 Erkrankungen pro 1 Mio. Einwohner. Im Kindesalter ist der Anteil maligner Knochentumoren mit 6% aller kindlichen Malignome größer als der entsprechende Anteil bei Erwachsenen. Der Altersgipfel der Gesamtheit aller Knochentumoren liegt zwischen 15 und 19 Jahren. Am häufigsten sind das Osteo- (35%), das Chondro- (25%) und das Ewing-Sarkom (16%). Seltener (≤ 5%) folgen Entitäten wie das Chordom, das primäre maligne fibröse Histiozytom (MFH) des Knochens und das Fibrosarkom des Knochens. Vaskuläre primäre maligne Knochentumoren und das Adamantinom sind sehr selten. Das für eine systematische Therapieableitung notwendige Staging beinhaltet eine vollständige bildgebende Diagnostik und die histopathologische Diagnosesicherung der Entität, welche im Fall von malignen Knochentumoren meist über eine Probebiopsie erfolgt. Darauf basierend muss in einer interdisziplinären Tumorkonferenz das individuelle therapeutische Vorgehen festgelegt werden. Die operative Therapie beinhaltet dabei zumeist die weite Tumorresektion und anschließende Rekonstruktion. Die engmaschige, kontinuierliche Tumornachsorge ist von essenzieller Bedeutung für die Prognose und sollte üblicherweise im behandlungsführenden Tumorzentrum fortgeführt werden.
Abstract
Among human neoplasms, primary malignant bone tumors are fairly rare. They present an incidence rate of roughly 10 cases per 1 million inhabitants per year. During childhood (<15 years), the percentage of malignant bone tumors amounts to 6% of all infantile malignancies. Only leukemia and lymphoma show a higher incidence in adolescence. Of all primary malignant bone tumors, 60% affect patients younger than 45 years and the peak incidence of all bone tumors occurs between 15 and 19 years. The most common primary malignant bone tumors are osteosarcoma (35%), chondrosarcoma (25%), and Ewing’s sarcoma (16%). Less frequently (≤ 5%) occurring tumors are chordoma, malignant fibrous histiocytoma of bone, and fibrosarcoma of bone. Vascular primary malignant tumors of bone and adamantinoma are very rare. Staging of the lesion is essential for systemic therapeutic decision-making and includes complete imaging and histo-pathological confirmation of the suspected entity. In most cases, this is established by open- or image-guided biopsy. Based on this information, an interdisciplinary tumor board will determine the individual therapeutic approach. Endoprosthetic or biological reconstruction following wide tumor resection is the most common surgical therapy for primary malignant bone tumors. There is vital importance in a thorough postoperative follow-up and continous after-care by a competent tumor center which is permanentely in charge of therapy.
Literatur
Abdelwahab IF, Klein MJ, Hermann G, Springfield D (1998) Angiosarcomas associated with bone infarcts. Skeletal Radiol 27(10):546–551
Addison AK, Payne SR (1982) Primary liposarcoma of bone. Case report. J Bone Joint Surg Am 64(2):301–304
Aurias A, Rimbaut C, Buffe D (1983) Chromosomal translocations in Ewing’s sarcoma. N Engl J Med 309(8):496–498
Ayerza MA, Farfalli GL, Aponte-Tinao L, Muscolo DL (2010) Does increased rate of limb-sparing surgery affect survival in osteosarcoma? Clin Orthop Relat Res 468(11):2854–2859. DOI 10.1007/s11999-010-1423-4
Bacci G, Picci P, Mercuri M et al (1998) Neoadjuvant chemotherapy for high grade malignant fibrous histiocytoma of bone. Clin Orthop Relat Res 346:178–189
Bacci G, Longhi A, Versari M et al (2006) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 106(5):1154–1161. DOI 10.1002/cncr.21724
Bacci G, Rocca M, Salone M et al (2008) High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol 98(6):415–420. DOI 10.1002/jso.21140
Balamuth NJ, Womer RB (2010) Ewing’s sarcoma. Lancet Oncol 11(2):184–192. DOI 10.1016/S1470-2045(09)70286-4
Bielack SS, Schroeders A, Fuchs N et al (1999) Malignant fibrous histiocytoma of bone: a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology Society. Acta Orthop Scand 70(4):353–360
Bjornsson J, McLeod RA, Unni KK et al (1998) Primary chondrosarcoma of long bones and limb girdles. Cancer 83(10):2105–2119
Bohm P, Fritz J, Thiede S, Budach W (2003) Reimplantation of extracorporeal irradiated bone segments in musculosceletal tumor surgery: clinical experience in eight patients and review of the literature. Langenbecks Arch Surg 387(9–10):355–365. DOI 10.1007/s00423-002-0332-8
Bovee JV (2008) Multiple osteochondromas. Orphanet J Rare Dis 3:3. DOI 10.1186/1750-1172-3-3
Camargo OP de, Baptista AM, Atanasio MJ, Waisberg DR (2010) Chondrosarcoma of bone: lessons from 46 operated cases in a single institution. Clin Orthop Relat Res 468(11):2969–2975. DOI 10.1007/s11999-010-1368-7
Campanacci M (1999) Bone and soft tissue tumors: clinical features, imaging, pathology and treatment, 2. Aufl. Springer, Berlin Heidelberg New York
Campanacci DA, Matera D, Franchi A, Capanna R (2008) Synovial chondrosarcoma of the hip: report of two cases and literature review. Chir Organi Mov 92(3):139–144. DOI 10.1007/s12306-008-0062-3
Capanna R, Bertoni F, Bacchini P et al (1984) Malignant fibrous histiocytoma of bone. The experience at the Rizzoli Institute: report of 90 cases. Cancer 54(1):177–187
Caudill JS, Arndt CA (2007) Diagnosis and management of bone malignancy in adolescence. Adolesc Med State Art Rev 18(1):62–78, ix
Cesari M, Bertoni F, Bacchini P et al (2007) Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution. Tumori 93(5):423–427
Chandawarkar RY (1996) Sacrococcygeal chordoma: review of 50 consecutive patients. World J Surg 20(6):717–719
Dantonello TM, Int-Veen C, Leuschner I et al (2008) Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups. Cancer 112(11):2424–2431. DOI 10.1002/cncr.23457
DeLaney TF, Liebsch NJ, Pedlow FX et al (2009) Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 74(3):732–739. DOI 10.1016/j.ijrobp.2008.08.058
Delattre O, Zucman J, Melot T et al (1994) The Ewing family of tumors – a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331(5):294–299. DOI 10.1056/NEJM199408043310503
Donati D, Colangeli S, Colangeli M et al (2010) Surgical treatment of grade I central chondrosarcoma. Clin Orthop Relat Res 468(2):581–589. DOI 10.1007/s11999-009-1056-7
Dorfman HD, Czerniak B (1995) Bone cancers. Cancer [Suppl 1] 75:203–210
Engels C, Werner M, Delling G (2000) Clear-cell chondrosarcoma. Pathologe 21(6):449–455
Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120
Fletcher C, Unni K, Mertens F (2002) World Health Organization classification of tumours: pathology and genetics of tumours of soft tissue and bone. Malignant fibrous histiocytoma of bone. IARC Press, Lyon
Frassica FJ, Unni KK, Beabout JW, Sim FH (1986) Dedifferentiated chondrosarcoma. A report of the clinicopathological features and treatment of seventy-eight cases. J Bone Joint Surg Am 68(8):1197–1205
Freyschmidt J, Jundt G, Ostertag H (2003) Knochentumoren: Klinik, Radiologie, Pathologie. Springer, Berlin Heidelberg New York
Grier HE (1997) The Ewing family of tumors. Ewing’s sarcoma and primitive neuroectodermal tumors. Pediatr Clin North Am 44(4):991–1004
Grimer RJ, Gosheger G, Taminiau A et al (2007) Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. Eur J Cancer 43(14):2060–2065. DOI 10.1016/j.ejca.2007.06.016
Hansen MF, Nellissery MJ, Bhatia P (1999) Common mechanisms of osteosarcoma and Paget’s disease. J Bone Miner Res [Suppl 2] 14:39–44
Hawkins DS, Arndt CA (2003) Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer 98(11):2447–2456. DOI 10.1002/cncr.11799
Heare T, Hensley MA, Dell’Orfano S (2009) Bone tumors: osteosarcoma and Ewing’s sarcoma. Curr Opin Pediatr 21(3):365–372. DOI 10.1097/MOP.0b013e32832b1111
Indelicato DJ, Keole SR, Shahlaee AH et al (2008) Long-term clinical and functional outcomes after treatment for localized Ewing’s tumor of the lower extremity. Int J Radiat Oncol Biol Phys 70(2):501–509. DOI 10.1016/j.ijrobp.2007.06.032
Jawad MU, Haleem AA, Scully SP (2011) Malignant sarcoma of the pelvic bones: treatment outcomes and prognostic factors vary by histopathology. Cancer 117(7):1529–1541. DOI 10.1002/cncr.25684
Kenan S, Lewis MM, Abdelwahab IF et al (1991) Case report 652: primary intraosseous low grade myxoid sarcoma of the scapula (myxoid liposarcoma). Skeletal Radiol 20(1):73–75
Kindblom LG (2009) Bone tumors: epidemiology, classification, pathology. Imaging of bone tumors and tumor-like lesions techniques and applications. Springer, Berlin Heidelberg New York
Klein MJ, Siegal GP (2006) Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol 125(4):555–581. DOI UC6KQHLD9LV2KENN [pii]. 10.1309/UC6K-QHLD-9LV2-KENN
Koplas MC, Lefkowitz RA, Bauer TW et al (2010) Imaging findings, prevalence and outcome of de novo and secondary malignant fibrous histiocytoma of bone. Skeletal Radiol 39(8):791–798. DOI 10.1007/s00256-009-0822-7
Lee FY, Mankin HJ, Fondren G et al (1999) Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 81(3):326–338
Link TM, Haeussler MD, Poppek S et al (1998) Malignant fibrous histiocytoma of bone: conventional X-ray and MR imaging features. Skeletal Radiol 27(10):552–558
Liu J, Hudkins PG, Swee RG, Unni KK (1987) Bone sarcomas associated with Ollier’s disease. Cancer 59(7):1376–1385
Matsuno T, Unni KK, McLeod RA, Dahlin DC (1976) Telangiectatic osteogenic sarcoma. Cancer 38(6):2538–2547
McDonald DJ, Enneking WF, Sundaram M (2002) Metal-associated angiosarcoma of bone: report of two cases and review of the literature. Clin Orthop Relat Res 396:206–214
Meister P, Konrad EA, Stotz S (1981) Extraskeletal osteosarcoma. Case report and differential diagnosis. Arch Orthop Trauma Surg 98(4):311–314
Meyer JS, Nadel HR, Marina N et al (2008) Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group Bone Tumor Committee. Pediatr Blood Cancer 51(2):163–170. DOI 10.1002/pbc.21596
Nakajima H, Sim FH, Bond JR, Unni KK (1997) Small cell osteosarcoma of bone. Review of 72 cases. Cancer 79(11):2095–2106
Pannier S, Legeai-Mallet L (2008) Hereditary multiple exostoses and enchondromatosis. Best Pract Res Clin Rheumatol 22(1):45–54. DOI 10.1016/j.berh.2007.12.004
Picci P, Bacci G, Ferrari S, Mercuri M (1997) Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors. Ann Oncol 8(11):1107–1115
Rechl HK, C, Wörtler K, Lenze U et al (2011) Diagnostik von malignen Knochen- und Weichteiltumoren. Orthopade Aug 28. [Epub ahead of print]. DOI 10.1007/s00132-011-1821-7
Rodriguez-Galindo C, Shah N, McCarville MB et al (2004) Outcome after local recurrence of osteosarcoma: the St. Jude Children’s Research Hospital experience (1970–2000). Cancer 100(9):1928–1935. DOI 10.1002/cncr.20214
Ruggieri P, Angelini A, Ussia G et al (2010) Surgical margins and local control in resection of sacral chordomas. Clin Orthop Relat Res 468(11):2939–2947. DOI 10.1007/s11999-010-1472-8
Sabo D, Bernd L, Buchner M et al (2003) Intraoperative extrakorporale Irradiation und Replantation (IEIR) in der lokalen Behandlung primär maligner Knochentumoren. Orthopade 32(11):1003–1012. DOI 10.1007/s00132-003-0565-4
Salzer-Kuntschik M, Delling G, Beron G, Sigmund R (1983) Morphological grades of regression in osteosarcoma after polychemotherapy – study COSS 80. J Cancer Res Clin Oncol [Suppl] 106:21–24
Unni KK (2001) Cartilaginous lesions of bone. J Orthop Sci 6(5):457–472
Unni KK, Dahlin DC, Beabout JW, Sim FH (1976) Chondrosarcoma: clear-cell variant. A report of sixteen cases. J Bone Joint Surg Am 58(5):676–683
Weeden S, Grimer RJ, Cannon SR et al (2001) The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer 37(1):39–46
Weiss A, Khoury JD, Hoffer FA et al (2007) Telangiectatic osteosarcoma: the St. Jude Children’s Research Hospital’s experience. Cancer 109(8):1627–1637. DOI 10.1002/cncr.22574
West DC (2000) Ewing sarcoma family of tumors. Curr Opin Oncol 12(4):323–329
Wick MR, Siegal GP, Unni KK et al (1981) Sarcomas of bone complicating osteitis deformans (Paget’s disease): fifty years‘ experience. Am J Surg Pathol 5(1):47–59
Wirth C, Zichner L (2005) Orthopädie und orthopädische Chirurgie: Tumoren, tumorähnliche Erkrankungen. Thieme, Stuttgart New York
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
von Eisenhart-Rothe, R., Toepfer, A., Salzmann, M. et al. Primär maligne Knochentumoren. Orthopäde 40, 1121–1142 (2011). https://doi.org/10.1007/s00132-011-1866-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00132-011-1866-7